Hidrosmin

DB13490InvestigationalSmall molecule

Hidrosmin is a synthetic bioflavonoid used for the short-term treatment of symptoms associated with chronic venous insufficiency. An antioxidant used to treat symptoms such as swelling in the legs caused by the accumulation of blood in veins.

Chemical structure of Hidrosmin
Formula / weight
C30H36O16 · 652.602 g/mol (avg)

Resolves to

Compound
UNII4I5K8199OQCAS115960-14-0ChEMBLCHEMBL3707286ChEBI135840
Clinical / RWD
ATCC05CA05
Structure
InChIKeyXYFLWVOTXWXNAM-WTNNCJBMSA-NSMILESCOC1=CC=C(C=C1O)C1=CC(=O)C2=C(OCCO)C=C(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)C=C2O1

What you can answer from here — as of April 02, 2025

1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
4Marketed productsAcross 2 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 8 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Hidrosmin, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In